- Home
- / L&C BIO
L&C BIO
Stock Price
₩18.4 K
2024-10-29
Market Capitalization
₩407.2 B
2024-10-29
Revenue
₩72.1 B
FY, 2024
L&C BIO Summary
Company Summary
- Overview
- L&C BIO (엘앤씨바이오) is a company that develops healthcare solutions. It offers prescription and OTC drugs, medical devices, human tissues, and cosmetics products.
- Type
- Public
- Status
- Active
- Founded
- 2011
- HQ
- Seongnam-si, KR | view all locations
- Website
- http://www.lncbio.co.kr
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Seongnam-si, Gyeonggi-do HQ
Korea (Republic of)
605 606, 474 Dunchon-daero, Jungwon-gu
L&C BIO Financials
Summary Financials
- Revenue (Q1, 2026)
- ₩30.3B
- Gross profit (Q1, 2026)
- ₩19.5B
- Net income (Q1, 2026)
- ₩2.7B
- Cash (Q1, 2026)
- ₩43.8B
- EBIT (Q1, 2026)
- ₩5.9B
- Enterprise value
- $450.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026